Medtecs International says it intends to make an application to transfer its listing from the Catalist to the Mainboard of the Singapore Exchange Securities Trading Limited (SGX-ST) on Nov 16.

The proposed transfer, according to the company, would better place the company to attract institutional investors and reach out to a wider investor base in Singapore and overseas.

The company also believes the transfer to the Mainboard would “enhance its image” and provide it with “greater visibility and recognition in the market”, which is “particularly critical in this Covid-19 pandemic situation”.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook